Preferred Label : Epstein-Barr Virus gp350-ferritin Nanoparticle Vaccine with Saponin-based Adjuvant;
NCIt synonyms : Epstein-Barr Virus gp350-ferritin Nanoparticle Vaccine with Matrix-M1 Adjuvant; EBV gp350-ferritin Vaccine; EBV gp350-ferritin Nanoparticle Vaccine with Saponin-based Adjuvant; EBV gp350-ferritin Vaccine/Matrix M1; EBV gp350-based Nanoparticle Vaccine;
NCIt definition : A ferritin-based, nanoparticle vaccine consisting of the Epstein-Barr Virus (EBV)
envelop glycoprotein gp350 and a saponin-based adjuvant, with potential immunizing
activity against EBV. Upon intramuscular administration of EBV gp350-ferritin nanoparticle
vaccine with saponin-based adjuvant, the EBV gp350 may activate both humoral and cellular
immune responses which may result in protection against EBV infection. EBV, a ubiquitous
human herpes virus, is associated with infectious mononucleosis and various malignancies,
including nasopharyngeal carcinoma, Hodgkin disease, non-Hodgkin lymphoma, and other
lymphomas.;
NCI Metathesaurus CUI : CL1661877;
Origin ID : C179302;
UMLS CUI : C5555596;
Semantic type(s)
- concept_is_in_subset
